Peter S. Hammerman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Peter S. Hammerman has a total of 216 co-authors. Here are the top co-authors by number of shared publications:
- Kwok-Kin Wong
Division of Hematology & Medical Oncology, NYU Langone Perlmutter Cancer Center, New York, USA
59 shared publications - Gordon J. Freeman
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
42 shared publications - Jun Qi
Department of Cancer Biology Dana‐Farber Cancer Institute Boston MA USA
34 shared publications - Matthew Meyerson
Broad Institute of MIT and Harvard, Cambridge, USA
34 shared publications - Aristotelis Tsirigos
Department of Pathology, New York University Grossman School of Medicine, New York, USA
32 shared publications Alexandra R. Rabin
30 shared publications
Latest Publications
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Figure S5 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Supplemental Figure S5 shows distribution of barcoded clones into Louvain clusters.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure S5 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Supplemental Figure S5 shows distribution of barcoded clones into Louvain clusters.
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Figure S7 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Supplemental Figure S7 shows clone family gene signature set expression at drug tolerance.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure S7 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Supplemental Figure S7 shows clone family gene signature set expression at drug tolerance.
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Figure S8 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Supplemental Figure S8 shows clone family contribution at drug resistance and sensitivity to drug combinations.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure S8 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Supplemental Figure S8 shows clone family contribution at drug resistance and sensitivity to drug combinations.
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Figure S1 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Supplemental Figure S1 shows barcode enrichment in drug treated cells, copy number segmentation, and xBC library cloning.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure S1 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Supplemental Figure S1 shows barcode enrichment in drug treated cells, copy number segmentation, and xBC library cloning.
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Figure S3 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Supplemental Figure S3 shows Louvain clusters overlaid onto UMAP plots and contribution of cells by time point.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure S3 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Supplemental Figure S3 shows Louvain clusters overlaid onto UMAP plots and contribution of cells by time point.
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Figure S6 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Supplemental Figure S6 shows clone family UMAPs, proportion change in response to drug, and gene signature set expression at untreated and acute drug treatment.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure S6 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Supplemental Figure S6 shows clone family UMAPs, proportion change in response to drug, and gene signature set expression at untreated and acute drug treatment.
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Figure and Table Legends from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Legends for Supplemental Figures and Tables
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure and Table Legends from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Legends for Supplemental Figures and Tables
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Figure S4 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Supplemental Figure S4 shows abundance of individual barcoded clones.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure S4 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Supplemental Figure S4 shows abundance of individual barcoded clones.
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Figure S2 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Supplemental Figure S2 shows UMAP plots, entropy analysis, quantification of barcode abundance, cell sensitivity to drug, and average gene signature set expression in sensitive vs tolerant clones.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure S2 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Supplemental Figure S2 shows UMAP plots, entropy analysis, quantification of barcode abundance, cell sensitivity to drug, and average gene signature set expression in sensitive vs tolerant clones.
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Tables 1 - 12 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Tables 1 - 12 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance